Form 4: Core Scientific Director Receives RSU Grant

Core Scientific director Elizabeth Crain was granted 18,575 restricted stock units, vesting in February 2027.

Summary

• Elizabeth Crain, a Director of Core Scientific, Inc. (CORZ), was granted 18,575 restricted stock units (RSUs).
• The transaction date for this grant was February 4, 2026.
• These RSUs will vest in full on February 3, 2027.
• Vesting is contingent upon Ms. Crain continuing to serve as a non-employee director for the Issuer on the vesting date.
• Following this transaction, Ms. Crain beneficially owns 65,348 shares of common stock.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, reflecting standard director compensation practices and an effort to align director interests with long-term company performance.

Positives

• The RSU grant aligns the director's interests with long-term shareholder value through equity ownership.
• The vesting condition incentivizes continued service and retention of a non-employee director.

Negatives

• The RSU grant represents a potential future dilution of existing shareholder equity upon vesting.

Risks

• There is a risk that the director may not continue service until the vesting date, resulting in forfeiture of the RSUs.
• The value of the RSUs upon vesting is subject to the future market price of Core Scientific's common stock.

Future Outlook

The grant of restricted stock units with a future vesting date indicates an expectation of continued service from the non-employee director through February 3, 2027.

Industry Context

StockSavvy.ai notes that granting restricted stock units to non-employee directors is a common practice across industries, particularly in technology and growth sectors like cryptocurrency mining, to align director incentives with long-term company performance and shareholder interests. This practice helps retain experienced board members.

Related Party Transactions

• The grant of 18,575 restricted stock units to Elizabeth Crain, a non-employee director, constitutes a related party transaction as it involves compensation to a member of the company's board.

Stakeholder Impact

• Shareholders: Potential future dilution upon vesting of RSUs; improved alignment of director's interests with long-term shareholder value.
• Director (Elizabeth Crain): Receives equity compensation, incentivizing continued service and performance.

Next Steps

• Elizabeth Crain to continue providing service as a non-employee director until February 3, 2027.
• Vesting of 18,575 RSUs on February 3, 2027, subject to continued service.

Key Dates

Recommendation

This Form 4 filing details a routine compensation event for a non-employee director and does not contain information that would fundamentally alter the investment thesis for Core Scientific. It is a standard corporate governance action aimed at aligning director incentives, and as such, does not warrant a change in investment recommendation based solely on this filing.

Keywords

Core Scientific, CORZ, Elizabeth Crain, Restricted Stock Units, RSU, Director Compensation, Insider Transaction, Equity Grant, Form 4, SEC Filing